NCT06715527View on ClinicalTrials.gov

Treatment of Women With Hyperandrogenic PCOS With Two Different Ratios of Myo-inositol:D-chiro-inositol: A Comparison

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

March 6, 2025

Study Completion Date

March 14, 2025

Conditions
Polycystic Ovarian Syndrome (PCOS)
Interventions
DIETARY_SUPPLEMENT

Myo-Inositol and D-Chiro-Inositol (40:1)

Myo-inositol and D-chiro-inositol (40:1 ratio), 2 grams (twice a day) for three months

DIETARY_SUPPLEMENT

Myo-Inositol and D-Chiro-Inositol (3.6:1)

Myo-inositol and D-chiro-inositol (3.6:1 ratio), 1.4 grams (once daily) for three months

Trial Locations (1)

00198

Alma Res Fertility Center, Rome

Sponsors

Lead Sponsor

Lo.Li.Pharma s.r.l
All Listed Sponsors
lead

Lo.Li.Pharma s.r.l

INDUSTRY

NCT06715527 - Treatment of Women With Hyperandrogenic PCOS With Two Different Ratios of Myo-inositol:D-chiro-inositol: A Comparison | Biotech Hunter | Biotech Hunter